|
SPG11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.915200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.949900E-02 |
| Normal-vs-Stage2 |
6.537800E-01 |
| Normal-vs-Stage3 |
7.8475999999994E-05 |
| Normal-vs-Stage4 |
3.619600E-04 |
| Stage1-vs-Stage2 |
3.149600E-01 |
| Stage1-vs-Stage3 |
6.781800E-03 |
| Stage1-vs-Stage4 |
2.608300E-02 |
| Stage2-vs-Stage3 |
1.403950E-02 |
| Stage2-vs-Stage4 |
2.269900E-02 |
| Stage3-vs-Stage4 |
9.069600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.604800E-03 |
| Normal-vs-AfricanAmerican |
2.354100E-02 |
| Normal-vs-Asian |
4.708600E-01 |
| Caucasian-vs-AfricanAmerican |
9.884400E-01 |
| Caucasian-vs-Asian |
7.401800E-01 |
| AfricanAmerican-vs-Asian |
7.037000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.763400E-04 |
| Normal-vs-Female |
9.782200E-02 |
| Male-vs-Female |
3.238200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.223500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.632100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.378000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.075700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.704190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.244000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.133400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.040200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.935600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.424600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.314200E-01 |
| Normal-vs-Grade 2 |
1.458640E-01 |
| Normal-vs-Grade 3 |
1.195820E-03 |
| Normal-vs-Grade 4 |
5.69539999606405E-08 |
| Grade 1-vs-Grade 2 |
1.494810E-01 |
| Grade 1-vs-Grade 3 |
4.576100E-02 |
| Grade 1-vs-Grade 4 |
3.971200E-04 |
| Grade 2-vs-Grade 3 |
2.482300E-02 |
| Grade 2-vs-Grade 4 |
5.882300000426E-07 |
| Grade 3-vs-Grade 4 |
7.413600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.287000E-01 |
| Normal-vs-ccB subtype |
4.36059999999738E-05 |
| ccA subtype-vs-ccB subtype |
9.31600000031452E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.728400E-02 |
| Normal-vs-N1 |
3.448400E-02 |
| N0-vs-N1 |
3.175000E-01 |
|
|
